UY29861A1 - Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral - Google Patents
Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oralInfo
- Publication number
- UY29861A1 UY29861A1 UY29861A UY29861A UY29861A1 UY 29861 A1 UY29861 A1 UY 29861A1 UY 29861 A UY29861 A UY 29861A UY 29861 A UY29861 A UY 29861A UY 29861 A1 UY29861 A1 UY 29861A1
- Authority
- UY
- Uruguay
- Prior art keywords
- oral
- combination
- dienogest
- dysfunctional uterine
- hemorragy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se efectúa el uso de valerato de estradiol en combinación con 17a(alfa)-cianometil-17-B(Beta)-hidroxiestra-4,9-dien-3-ona (dienogest) para producir un preparado combinado polifásico para la terapia oral de hemorragia uterina disfuncional en combinación con una anticoncepción oral. Todas las unidades de dosis diarias de la combinación polifásica y del placebo farmacéuticamente inocuo corresponden a 28 días. La duración de la aplicación comprende al menos un ciclo de ingesta y depende del deseo individual de la mujer de la anticoncepción.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05022324A EP1787649B1 (de) | 2005-10-13 | 2005-10-13 | Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY29861A1 true UY29861A1 (es) | 2007-05-31 |
Family
ID=35811580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY29861A UY29861A1 (es) | 2005-10-13 | 2006-10-13 | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral |
Country Status (22)
| Country | Link |
|---|---|
| EP (2) | EP1787649B1 (es) |
| JP (2) | JP5735200B2 (es) |
| KR (2) | KR101218872B1 (es) |
| CN (1) | CN101312733A (es) |
| AR (1) | AR056694A1 (es) |
| AT (2) | ATE424828T1 (es) |
| CA (1) | CA2623024C (es) |
| CL (1) | CL2011000283A1 (es) |
| CY (2) | CY1110321T1 (es) |
| DE (2) | DE502005006837D1 (es) |
| DK (2) | DK1787649T3 (es) |
| DO (1) | DOP2006000221A (es) |
| ES (2) | ES2322479T3 (es) |
| HR (1) | HRP20090256T1 (es) |
| ME (1) | ME01056B (es) |
| PE (2) | PE20100090A1 (es) |
| PL (2) | PL1787649T3 (es) |
| PT (2) | PT1787649E (es) |
| SI (2) | SI1787649T1 (es) |
| TW (2) | TWI328453B (es) |
| UY (1) | UY29861A1 (es) |
| WO (1) | WO2007042296A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| DK1787649T3 (da) * | 2005-10-13 | 2009-06-02 | Bayer Schering Pharma Ag | Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
| DE19540253C2 (de) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
| JP2000515889A (ja) * | 1996-07-26 | 2000-11-28 | アメリカン・ホーム・プロダクツ・コーポレイション | プロゲスチンとエストロゲンとの混合剤からなる二相性避妊法およびキット |
| US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
| EP1462106A1 (en) * | 2003-03-28 | 2004-09-29 | Pantarhei Bioscience B.V. | Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders |
| DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| DK1787649T3 (da) * | 2005-10-13 | 2009-06-02 | Bayer Schering Pharma Ag | Anvendelse af estradiovalerat i kombination med dienogest til oral behandling af dysfunktionel uterin blöding i enhed med en oral kontraception |
-
2005
- 2005-10-13 DK DK05022324T patent/DK1787649T3/da active
- 2005-10-13 PL PL05022324T patent/PL1787649T3/pl unknown
- 2005-10-13 ES ES05022324T patent/ES2322479T3/es active Active
- 2005-10-13 ME MEP-2009-171A patent/ME01056B/me unknown
- 2005-10-13 PT PT05022324T patent/PT1787649E/pt unknown
- 2005-10-13 DE DE502005006837T patent/DE502005006837D1/de active Active
- 2005-10-13 AT AT05022324T patent/ATE424828T1/de active
- 2005-10-13 EP EP05022324A patent/EP1787649B1/de not_active Revoked
- 2005-10-13 SI SI200530672T patent/SI1787649T1/sl unknown
-
2006
- 2006-10-12 PE PE2009001256A patent/PE20100090A1/es not_active Application Discontinuation
- 2006-10-12 TW TW095137564A patent/TWI328453B/zh active
- 2006-10-12 DK DK06806225.6T patent/DK1933843T3/da active
- 2006-10-12 KR KR1020107014574A patent/KR101218872B1/ko active IP Right Grant
- 2006-10-12 EP EP06806225A patent/EP1933843B1/de active Active
- 2006-10-12 CA CA2623024A patent/CA2623024C/en active Active
- 2006-10-12 WO PCT/EP2006/009867 patent/WO2007042296A1/de active Application Filing
- 2006-10-12 PE PE2006001241A patent/PE20070555A1/es not_active Application Discontinuation
- 2006-10-12 DE DE502006008853T patent/DE502006008853D1/de active Active
- 2006-10-12 SI SI200630991T patent/SI1933843T1/sl unknown
- 2006-10-12 ES ES06806225T patent/ES2360302T3/es active Active
- 2006-10-12 AT AT06806225T patent/ATE497387T1/de active
- 2006-10-12 PT PT06806225T patent/PT1933843E/pt unknown
- 2006-10-12 JP JP2008534936A patent/JP5735200B2/ja active Active
- 2006-10-12 CN CNA2006800381810A patent/CN101312733A/zh active Pending
- 2006-10-12 PL PL06806225T patent/PL1933843T3/pl unknown
- 2006-10-12 KR KR1020087011203A patent/KR20080065651A/ko not_active Application Discontinuation
- 2006-10-13 UY UY29861A patent/UY29861A1/es not_active Application Discontinuation
- 2006-10-13 DO DO2006000221A patent/DOP2006000221A/es unknown
- 2006-10-13 AR ARP060104489A patent/AR056694A1/es not_active Application Discontinuation
-
2007
- 2007-01-09 TW TW096100872A patent/TW200829255A/zh unknown
-
2009
- 2009-05-05 HR HR20090256T patent/HRP20090256T1/xx unknown
- 2009-06-11 CY CY20091100621T patent/CY1110321T1/el unknown
-
2011
- 2011-02-10 CL CL2011000283A patent/CL2011000283A1/es unknown
- 2011-05-02 CY CY20111100422T patent/CY1111406T1/el unknown
-
2012
- 2012-11-19 JP JP2012253067A patent/JP2013047269A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2561810T3 (es) | Antagonistas de progesterona tales como CDB-4124 para reducir el dolor asociado a endometriosis y fibroides uterinos | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
| AR048722A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| UY29861A1 (es) | Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
| CR8010A (es) | Regimenes de contraceptivos transdermicos extendidos | |
| JP2013047269A5 (es) | ||
| AR049195A1 (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
| DOP2006000035A (es) | Preparación farmaceútica para la anticoncepción oral | |
| PE20070769A1 (es) | Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional | |
| AR039227A1 (es) | Terapia de reemplazo hormonal | |
| DOP2010000017A (es) | Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| AR039228A1 (es) | Terapia de reemplazo hormonal | |
| ECSP034606A (es) | Uso de antiprogestinas para la induccion de apoptosis en una celula | |
| AR049220A1 (es) | Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos | |
| DOP2007000122A (es) | Forma farmacologica peroral para anticoncepcion | |
| AR056674A1 (es) | Anticoncepcion oral con trimegestona | |
| AR039477A1 (es) | Terapia de reemplazo hormonal | |
| RS50849B (sr) | Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu | |
| TH84327B (th) | การใช้และชุดสำเร็จรูปแอนโดรเจนสเตอรอยด์ (Androgenic Steriod) แบบที่ไม่ใช้รับประทานในสุภาพสตรี | |
| PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RDES | Application refused |
Effective date: 20190228 |